Annonce

Log ud Log ind
Log ud Log ind
Formue

The Lancet: Russisk COVID-19 vaccine er sikker og effektiv

Morten W. Langer

fredag 04. september 2020 kl. 17:29

Fra Zerohedge:

Dr. Scott Gottlieb might soon be forced to eat his words.

Trial results reported Friday by the Lancet, the British medical journal responsible for publishing some of the earliest research on the coronavirus, found that Russia’s Gameleya Institute-developed SARS-CoV-2 vaccine is both effective and safe, though scientists cautioned that long-term study is still required.

The vaccine, the researchers found, produced an antibody response in all test subjects while causing no serious adverse effects. The results mark the latest stamp of legitimacy for the vaccine developed by the world-reknowned Gameleya Institute, and show how the early and intense skepticism expressed by some in the West might have been premature.

The Lancet broke down the results in a series of eight tweets published by its official twitter account.

Russian officials maintain that the vaccine will be made available on an emergency basis in late October or early November. President Trump is desperately scrambling for a US vaccine alternative that can be credibly approved on an emergency basis, so he can say the same.

Meanwhile, in the US…

Read the full Lancet study below:

Pi is 0140673620318663 by Zerohedge on Scribd

 

Tilmeld dig vores gratis nyhedsbrev
ØU Top100 Finansvirksomhed

Få de vigtigste om bank, realkredit, forsikring, pension
Udkommer hver mandag.

Jeg giver samtykke til, at I sender mig mails med de seneste historier fra Økonomisk Ugebrev. Lejlighedsvis må I gerne sende mig gode tilbud og information om events. Samtidig accepterer jeg ØU’s Privatlivspolitik.

Du kan til enhver tid afmelde dig med et enkelt klik.

[postviewcount]

Jobannoncer

Controller/økonomimedarbejder – få den brede vifte af økonomiopgaver
Region H
Finance/Business Controller til Anzet A/S
Region Sjælland
CEO for Rejsekort & Rejseplan A/S
Region H
Liftra ApS i Aalborg søger en Finance Controller med ”speciale” i Transfer Pricing
Region Nordjylland

Mere fra ØU Formue

Log ind

Har du ikke allerede en bruger? Opret dig her.

FÅ VORES STORE NYTÅRSUDGAVE AF FORMUE

Her er de 10 bedste aktier i 2022

Tilbuddet udløber om:
dage
timer
min.
sek.

Analyse af og prognoser for Fixed Income (statsrenter og realkreditrenter)

Direkte adgang til opdaterede analyser fra toneangivende finanshuse:

Goldman Sachs

Fidelity

Danske Bank

Morgan Stanley

ABN Amro

Jyske Bank

UBS

SEB

Natixis

Handelsbanken

Merril Lynch 

Direkte adgang til realkreditinstitutternes renteprognoser:

Nykredit

Realkredit Danmark

Nordea

Analyse og prognoser for kort rente, samt for centralbankernes politikker

Links:

RBC

Capital Economics

Yardeni – Central Bank Balance Sheet 

Investing.com: FED Watch Monitor Tool

Nordea

Scotiabank